Literature DB >> 17012846

Epigenetic activation of tumor suppressor microRNAs in human cancer cells.

Yoshimasa Saito1, Peter A Jones.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that function as endogenous post-transcriptional silencers of target genes. miRNAs are expressed in a tissue specific manner and play important roles in cell proliferation, apoptosis and differentiation during animal development. Recent studies have shown a distinct connection between aberrant expression of miRNAs and the development of cancer, suggesting that miRNAs can be potential therapeutic targets. Our recent study has shown that some miRNAs are controlled by epigenetic alterations such as DNA methylation and histone modification in human cancer cells. Activation of tumor suppressor miRNAs by chromatin modifying drugs may cause downregulation of target oncogenes and could be a novel strategy for the prevention and treatment of human cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17012846     DOI: 10.4161/cc.5.19.3340

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  109 in total

Review 1.  Non-coding RNAs in cancer initiation and progression and as novel biomarkers.

Authors:  S Patrick Nana-Sinkam; Carlo M Croce
Journal:  Mol Oncol       Date:  2011-10-31       Impact factor: 6.603

Review 2.  Epigenetics of kidney cancer and bladder cancer.

Authors:  Amanda M Hoffman; Paul Cairns
Journal:  Epigenomics       Date:  2011-02       Impact factor: 4.778

Review 3.  Epigenetic alterations in aging.

Authors:  Susana Gonzalo
Journal:  J Appl Physiol (1985)       Date:  2010-05-06

Review 4.  Epigenetics and colorectal cancer.

Authors:  Victoria Valinluck Lao; William M Grady
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-18       Impact factor: 46.802

Review 5.  A role for epigenetics in hearing: Establishment and maintenance of auditory specific gene expression patterns.

Authors:  Matthew J Provenzano; Frederick E Domann
Journal:  Hear Res       Date:  2007-07-19       Impact factor: 3.208

Review 6.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

7.  Myeloid leukemia with high EVI1 expression is sensitive to 5-aza-2'-deoxycytidine by targeting miR-9.

Authors:  F Li; W He; R Geng; X Xie
Journal:  Clin Transl Oncol       Date:  2019-05-03       Impact factor: 3.405

8.  The role of microRNAs in gastrointestinal cancers.

Authors:  Yoshimasa Saito; Hidekazu Suzuki; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

Review 9.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

Review 10.  Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Authors:  Robert C Smallridge; Laura A Marlow; John A Copland
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.